Journal article · 2008 · Open access

Present and prospective clinical therapeutic regimens for Alzheimer’s disease

Mustafa M. Husain, Kenneth Treviño, Haroon Siddique, Shawn M. McClintock

Neuropsychiatric Disease and Treatment, 4(4), 765 · Published 1 September 2008 · DOI 10.2147/ndt.s2012

Free PDFView at the publisherCite this paper

In brief

“Present and prospective clinical therapeutic regimens for Alzheimer’s disease” is a 2008 journal article by Mustafa M. Husain and 3 co-authors, published in Neuropsychiatric Disease and Treatment. OpenAlex counts 21 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Neuropsychiatric Disease and Treatment.

Citations
21
Most cited in
2012 (3)
Field-weighted impact
1.23
References
152
Authors
4

Abstract

Alzheimer's disease (AD) is an incurable neurodegenerative disorder that produces cognitive impairments that increase in severity as the disease progresses. The clinical symptoms are related to the presence of neuritic plaques and neurofibrillary tangles in the cerebral cortex which represent the pathophysiological hallmarks of AD. The debilitating nature of the disease can result in clinical burden for the patient, emotional strain for those that care for patients with Alzheimer's, and significant financial burden to society. The goals of current treatments, such as cholinesterase inhibitors and N-methyl-D-aspartate receptor antagonist, are to reduce the severity or slow the progression of cognitive symptoms. Although these treatments have demonstrated modest clinical benefit, they are unable to prevent, prohibit, or reverse the underlying pathophysiology of AD. Considerable progress has been made toward the development of disease-modifying treatments. Treatments currently under development mainly target the production, aggregation, and removal of existing amyloid beta-peptide aggregates which are believed to instigate the overall development of the neuropathology. Additional strategies that target tau pathology are being studied to promote neural protection against AD pathology. The current research has continued to expand our knowledge toward the development of disease modifying Alzheimer's therapies; however, no specific treatment strategy capable of demonstrating empirical efficacy and safety has yet to emerge.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Husain, M. M., Treviño, K., Siddique, H., & McClintock, S. M. (2008). Present and prospective clinical therapeutic regimens for Alzheimer’s disease. Neuropsychiatric Disease and Treatment, 4(4), 765. https://doi.org/10.2147/ndt.s2012

MLA 9

Husain, Mustafa M., et al. “Present and prospective clinical therapeutic regimens for Alzheimer’s disease.” Neuropsychiatric Disease and Treatment, vol. 4, no. 4, 2008, p. 765. https://doi.org/10.2147/ndt.s2012.

Chicago

Husain, Mustafa M., Kenneth Treviño, Haroon Siddique, and Shawn M. McClintock. 2008. “Present and prospective clinical therapeutic regimens for Alzheimer’s disease.” Neuropsychiatric Disease and Treatment 4 (4): 765. https://doi.org/10.2147/ndt.s2012.

Harvard

Husain, M. M. et al. (2008) ‘Present and prospective clinical therapeutic regimens for Alzheimer’s disease’, Neuropsychiatric Disease and Treatment, 4(4), p. 765. doi:10.2147/ndt.s2012.

IEEE

M. M. Husain, K. Treviño, H. Siddique, and S. M. McClintock, “Present and prospective clinical therapeutic regimens for Alzheimer’s disease,” Neuropsychiatric Disease and Treatment, vol. 4, no. 4, p. 765, 2008, doi: 10.2147/ndt.s2012.

BibTeX

@article{husain2008present,
  title     = {{Present and prospective clinical therapeutic regimens for Alzheimer’s disease}},
  author    = {Husain, Mustafa M. and Treviño, Kenneth and Siddique, Haroon and McClintock, Shawn M.},
  journal   = {Neuropsychiatric Disease and Treatment},
  year      = {2008},
  volume    = {4},
  number    = {4},
  pages     = {765},
  doi       = {10.2147/ndt.s2012},
  url       = {https://doi.org/10.2147/ndt.s2012}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201233
201311
201411
201611
201833
201911
202511

Its field-weighted citation impact is 1.23: it has been cited 1.23 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • cholinesterase inhibitors
  • NMDA receptor antagonists
  • disease-modifying therapy
  • amyloid-beta
  • tau pathology
  • neuritic plaques
  • neurofibrillary tangles

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Husain, M. M., Treviño, K., Siddique, H., & McClintock, S. M. (2008). Present and prospective clinical therapeutic regimens for Alzheimer’s disease. Neuropsychiatric Disease and Treatment, 4(4), 765. https://doi.org/10.2147/ndt.s2012

How many times has this paper been cited?

21 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Neuropsychiatric Disease and Treatment.

Who wrote this paper?

Mustafa M. Husain, Kenneth Treviño, Haroon Siddique, Shawn M. McClintock.

What is the DOI of this paper?

10.2147/ndt.s2012. The permanent link is https://doi.org/10.2147/ndt.s2012.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.